Tuberculosis Nursing Care
On this page
Direct answer
Two sputum smears open and close the tuberculosis care pathway under India's National Tuberculosis Elimination Programme: diagnosis by sputum microscopy (spot and early-morning samples), daily directly observed therapy with fixed-dose combination tablets — isoniazid, rifampicin, pyrazinamide and ethambutol for two months, then isoniazid and rifampicin for four — and follow-up sputum examination at defined months to confirm cure. Nursing runs the human side of this machinery: ensuring supervised swallowing, tracing defaulters, teaching cough etiquette and airborne precautions, and catching drug toxicity — orange-red urine on rifampicin is expected, red-green colour blindness on ethambutol is an emergency referral, and pyridoxine covers isoniazid's peripheral neuropathy.
What you must remember
- Programme identity: the RNTCP was renamed the National Tuberculosis Elimination Programme in 2020, targeting TB elimination by 2025 — earlier than the global end-TB date, and a favourite exam fact.
- Regimen logic: intensive phase HRZE daily for 2 months, continuation phase HR daily for 4 months in drug-susceptible pulmonary TB, as fixed-dose combinations; DOTS means every dose is swallowed under observation — the treatment supporter watches and records.
- Sputum follow-up schedule: end of the intensive phase (2 months), then 3, 5 and 6 months; persistence at 2-3 months triggers evaluation for non-response, drug resistance or non-tuberculous causes.
- Drug toxicity map: isoniazid — peripheral neuropathy (prevent with pyridoxine), hepatitis; rifampicin — orange discolouration of urine and secretions (teach it, or the patient stops the drug), hepatitis, drug interactions including oral contraceptive failure; pyrazinamide — hyperuricaemia, gout, hepatitis; ethambutol — retrobulbar neuritis with blurred vision and red-green colour discrimination loss, an indication to stop and refer.
- Airborne precautions: cough etiquette, natural cross-ventilation, surgical mask on the coughing patient, N95 respirator for staff in drug-resistant wards, and separate wards for MDR/RR-TB patients.
- The nurse as TB Health Visitor: registers the patient in NIKSHAY (the case-tracking portal), counsels on adherence and nutrition, traces defaulters door to door, screens household contacts, and arranges sputum collection.
- Nutrition and support: undernutrition both predicts and worsens TB; monthly nutrition support under the Ni-kshay Poshan scheme is part of the package the nurse must explain.
- Red flags during therapy: jaundice, persistent vomiting, rash, visual changes, joint pains, and worsening symptoms at 2-3 months — any of these means physician review, not self-adjustment.
Six months with one patient, seen whole
A 34-year-old mill worker is diagnosed with sputum-positive pulmonary TB: two samples collected (one spot, one early morning), registered in NIKSHAY, and treatment started the same week with a designated treatment supporter in his village. Month one: the nurse counsels through the fright — the orange urine is the rifampicin, the pyridoxine tablet guards his nerves, and the missing work days are survivable only if the full course completes. Month two: sputum re-check — negative, into the continuation phase; his wife is screened and the children evaluated per contact guidelines. Month four: feeling entirely well, he skips a week of collection; the defaulter list catches it, a home visit retrieves him, and the adherence conversation is factual, not scolding. Month six: final sputum negative — cured, documented, and the closing counselling covers relapse recognition, tobacco cessation and nutrition. Every one of those steps was a nursing task; the drugs were the easy part.
The Indian practice context
India carries the world's highest TB burden, which is why NTEP roles saturate the INC community health syllabus and staff nurse vacancies in Designated Microscopy Centres and Drug-Resistant TB Centres. Stigma does more damage than drug resistance in many villages — a woman hiding her diagnosis from her in-laws cannot attend supervised dosing at a centre, so the programme's community-linked treatment supporters and flexible observation points exist precisely for her. Confidentiality is absolute: status is not disclosed to employers or relatives without consent. The nurse balances airborne precautions with humanity — the mask is for the coughing patient's contact with others, not a badge of fear at the bedside — and in MDR-TB wards the N95, daily symptom review, and counselling through 9-24 month regimens make nursing the determining factor in who completes treatment.
Frequently asked questions
When are follow-up sputum examinations done under NTEP?
At the end of the intensive phase (2 months) and at 3, 5 and 6 months for drug-susceptible pulmonary TB, with persistent positivity at 2-3 months prompting evaluation for resistance or non-response.
Which anti-tubercular drug causes visual toxicity and how?
Ethambutol causes retrobulbar (optic) neuritis — blurred vision and loss of red-green colour discrimination — requiring immediate drug stoppage and referral to protect sight.
Why is pyridoxine given with isoniazid?
Isoniazid induces pyridoxine deficiency causing peripheral neuropathy; routine supplementation prevents the numbness and tingling that would otherwise complicate long therapy.
What mask protection applies on an MDR-TB ward?
Staff wear fitted N95 respirators; patients wear surgical masks when moving about; plain cloth masks protect nobody.
What does DOTS actually require?
Government-supplied fixed-dose drugs, taken daily and swallowed under direct observation by a designated supporter, with follow-up sputum testing and defaulter tracing — the DOTS elements in practice.